Eli Lilly

Page 3 of 7

Roche stock is falling after report its Wegovy challenger is causing patients to vomit
Health

Roche stock is falling after report its Wegovy challenger is causing patients to vomit

By Naomi Kresge and Bloomberg
September 12, 2024
Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
Newsletters

Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’

By
September 10, 2024
In this year’s Global 500 list: Energy woes, retail gains, and boom times for AI and weight-loss drugs
Newsletters

In this year’s Global 500 list: Energy woes, retail gains, and boom times for AI and weight-loss drugs

By
August 5, 2024
How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
Magazine

How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut

By
August 2, 2024
Thomas Schinecker, chief executive officer of Roche
Finance

Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss

By
July 29, 2024
A bathroom scale is surrounded by colorful pills.
Health

Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots

By Damian Garde and Bloomberg
July 11, 2024
A person using Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that manufactures Ozempic, has reported record quarterly results, up almost 3% on the stock market. The company's revenues rose by 38% to DKK 58.73 billion, some 7.8 billion euros. Ozempic is a diabetic drug that causes a loss of up to 15% of body weight because it acts as an appetite suppressant, a side effect that has made the drug fashionable on social media as a weight loss drug.
Features

Ozempic and Wegovy are marketed as a short-term holy grail for weight loss by some startups. Doctors disagree

By Jessica Mathews and Alena Botros
July 9, 2024
Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early
Commentary

Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early

By
July 2, 2024
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
Health

Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs

By
June 28, 2024
Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers
Health

Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers

By Matthew Perrone and The Associated Press
June 11, 2024
Nestle CEO Mark Schneider
Retail

Nestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs

By
May 21, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
Retail

Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition

By Naomi Kresge and Bloomberg
May 2, 2024
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
Health

FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug

By Tom Murphy, Matthew Perrone and The Associated Press
March 8, 2024
tube of wegovy injections
Lifestyle

Novo Nordisk eclipses Tesla on positive trial results for a weight loss drug that may be more powerful than its own Wegovy 

By
March 8, 2024
WHO
Health

A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says

By Naomi Kresge, Angela Feliciano and Bloomberg
March 1, 2024

Most Popular